A meta-analysis of clinical benefit rates for fulvestrant...

  • Main
  • 2019 / 5
  • A meta-analysis of clinical benefit rates for fulvestrant...
Breast Cancer 2019 / 5

A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer

Robertson, John F. R., Jiang, Zefei, Di Leo, Angelo, Ohno, Shinji, Pritchard, Kathleen I., Ellis, Matthew, Bradbury, Ian, Campbell, Christine
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Breast Cancer
DOI:
10.1007/s12282-019-00973-4
Date:
May, 2019
File:
PDF, 629 KB
english, 2019
Conversion to is in progress
Conversion to is failed